Jiangsu Hengrui Pharmaceuticals Co.,Ltd (HKG:1276)
73.70
+0.80 (1.10%)
At close: Dec 5, 2025
HKG:1276 Market Cap
HKG:1276 has a market cap or net worth of 450.97 billion as of December 5, 2025. Its market cap has increased by 33.11% in one year.
Market Cap
450.97B
Enterprise Value
407.07B
Revenue
33.86B
Ranking
n/a
PE Ratio
55.25
Stock Price
73.70
Market Cap Chart
Since October 20, 2000, HKG:1276's market cap has increased from 2.43B to 450.97B, an increase of 18,480.67%. That is a compound annual growth rate of 23.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 450.97B | 45.20% |
| Dec 31, 2024 | 310.59B | -1.97% |
| Dec 29, 2023 | 316.84B | 14.05% |
| Dec 30, 2022 | 277.81B | -29.95% |
| Dec 31, 2021 | 396.57B | -43.57% |
| Dec 31, 2020 | 702.75B | 62.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 277.93B |
| Hansoh Pharmaceutical Group Company | 253.90B |
| JD Health International | 192.73B |
| Innovent Biologics | 157.67B |
| WuXi Biologics | 134.32B |
| Sino Biopharmaceutical | 122.28B |
| Akeso | 114.31B |
| Sichuan Kelun-Biotech Biopharmaceutical | 107.27B |